ADC Therapeutics's total assets for Q3 2024 were $349.08M, a decrease of -6.11% from the previous quarter. ADCT total liabilities were $521.02M for the fiscal quarter, a 3.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.